Capitalization table
6 share classes, by liquidation seniority| Class | Authorized | Liq. pref | Participation | Issue price | % owned |
|---|---|---|---|---|---|
| Seed-1 | 7,212,058 | ▮ | ▮ | ▮ | ▮ |
| Seed-2 | 1,838,301 | ▮ | ▮ | ▮ | ▮ |
| Seed-3 | 3,370,968 | ▮ | ▮ | ▮ | ▮ |
| Series A-1 | 18,109,063 | ▮ | ▮ | ▮ | ▮ |
| Series A-2 | 4,031,183 | ▮ | ▮ | ▮ | ▮ |
| Series A-3 | 878,104 | ▮ | ▮ | ▮ | ▮ |
Membership and data by Private Market View
- ·Post-money valuations for 4 rounds
- ·The complete investor list: 29 names
- ·Watch Neurophos: the Monday email on marks, rounds and moves
Reading Neurophos's cap table
Share classes are listed senior-first: in a sale or liquidation, higher-seniority preferred stock is paid its liquidation preference before junior classes and common see proceeds. A participating class takes its preference and shares in the remainder; a non-participating class chooses one or the other.
The original issue price is what investors paid per share in that class’s round — read against current secondary prices, it shows which investors are above or below water.
Frequently asked about Neurophos
- How many share classes does Neurophos have?
- Neurophos has 6 recorded share classes, listed by liquidation seniority — Seed-1 is the most senior.
- How many shares has Neurophos authorized?
- Across its 6 recorded classes, Neurophos has authorized 35,439,677 shares.
- Where does Neurophos's cap table come from?
- Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Neurophos's 5 recorded funding rounds.